The FTSE 100 ended a difficult week firmly in negative territory on Friday, dragged lower by surging oil prices and growing unease over artificial intelligence investment returns. The blue-chip index closed down
The US Department of Justice has launched a fresh legal assault on UC Berkeley School of Law, accusing the institution of rigging its admissions process to favour Black applicants. The government’s central
More
GSK (LSE: GSK) shares are trading at levels last seen approximately a quarter of a century ago, a troubling milestone for one of Britain’s most prominent blue-chip companies. Back in March 1999,
More
On a warm, cloudless Tuesday morning in September 2001, the United States suffered the deadliest terrorist attack in its history, changing the world forever. At 8.46 am, American Airlines Flight 11, a
More
At a busy city intersection, problems rarely arrive one at a time. A bus falls behind schedule after getting caught in a queue. A driver enters the junction on green but cannot
More
Paysign, Inc. (PAYS) has developed a purpose-built large language model at the core of its ClaimGuardRx platform, targeting fraud and diversion in patient affordability programmes. Bryan Dennison, Senior Vice President of Sales
More
California’s Business and Consumer Services Agency has announced that scrutinising businesses’ use of artificial intelligence and emerging technologies will be a central enforcement priority. BCSA Secretary Rohit Chopra made the announcement on
More
President Donald Trump has indicated he is open to pardoning Michael Cohen, his former personal attorney who played a central role in his criminal conviction. Trump made the comments to reporters, suggesting
More
EMCOR Group (EME) has seen analysts raise their earnings forecasts, drawing renewed attention from investors tracking the engineering and construction giant. Upward revisions to earnings estimates are widely regarded as a bullish
More
The FTSE 100 fell under pressure as the European Central Bank pushed through another interest rate increase, unsettling investors across European equity markets. Oil prices climbed sharply above $105 per barrel, adding
More
AbbVie has announced positive topline results from its Phase 3 LUNA study evaluating atogepant for the preventive treatment of menstrual migraine in adults. Atogepant, sold as Qulipta in the US and Aquipta
More